Log in to save to my catalogue

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag8...

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag8...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1012696547

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B

About this item

Full title

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

Clinical & developmental immunology, 2012-01, Vol.2012 (2012), p.1-9

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Recombinant Bacillus Calmette-Guérin (rBCG) strain is the promising vaccine candidate for tuberculosis (TB) prevention, which aims at providing more enduring and enhanced protection than the parental BCG vaccine. In this study, three rBCG strains overexpressing immunodominant antigens Ag85B (rBCG::85B), Ag85A (rBCG::85A), or both (rBCG::AB) of Myco...

Alternative Titles

Full title

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1012696547

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1012696547

Other Identifiers

ISSN

1740-2522,2314-8861

E-ISSN

1740-2530,2314-7156

DOI

10.1155/2012/563838

How to access this item